Optimizing scleral lens prescriptions: a comparison of algorithmic and conventional refraction and over-refraction in irregular corneas.

Cont Lens Anterior Eye

Clinical & Experimental Optometry Research Lab (CEORLab), Physics Center of Minho and Porto Universities (CF-UM-UP), University of Minho, Braga, Portugal. Electronic address:

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: To compare the accuracy and consistency of subjective refraction using conventional methods versus an algorithm-based approach in patients with primary or secondary corneal irregularities, both with and without scleral lenses (SL).

Methods: Nineteen eyes of ten subjects with irregular corneas underwent non-cycloplegic refraction using (I) retinoscopy followed by conventional subjective refraction (Conventional Refraction) to achieve maximum visual acuity with the maximum positive prescription, and (II) a Hartmann-Shack wavefront aberrometer (WAM 800) followed by an algorithm-based semi-automatic phoropter (Vision-R 800). Refraction measurements were conducted with both techniques, without and with SLs. Outcomes included spherical equivalent (M) and astigmatic components (J0 and J45), and monocular high and low-contrast visual acuity (HCVA and LCVA).

Results: Without SLs, the mean difference in the spherical equivalent between methods was -0.80 ± 1.20 D (p = 0.001). With SLs, the mean difference was -1.04 ± 0.93 D (p = 0.001). Without SLs, monocular HCVA was 0.21 ± 0.20 LogMAR (range: -0.10 to 0.76) and 0.17 ± 0.14 LogMAR (range: -0.02 to 0.60) for Conventional Refraction and V-R 800 (p = 0.162), respectively. Monocular LCVA was 0.59 ± 0.22 LogMAR (range: 0.18 to 0.96) and 0.53 ± 0.20 LogMAR (range: 0.10 to 0.92) for Conventional Refraction and V-R 800, respectively (p = 0.060). With SLs, HCVA was 0.12 ± 0.16 LogMAR (range: -0.12 to 0.50) and 0.09 ± 0.11 LogMAR (range: -0.08 to 0.26) for Conventional Refraction and V-R 800 (p = 0.272), respectively. LCVA was 0.43 ± 0.20 LogMAR (range: 0.06 to 0.90) and 0.47 ± 0.15 LogMAR (range: 0.18 to 0.88), respectively (p = 0.287).

Conclusions: Algorithm-based refraction method provided a more positive spherical equivalent than conventional methods, and both techniques resulted in comparable HCVA and LCVA. Algorithm-based refraction may offer an alternative for over-refraction in patients with irregular corneas during SLs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clae.2025.102485DOI Listing

Publication Analysis

Top Keywords

logmar range
32
conventional refraction
20
irregular corneas
12
spherical equivalent
12
refraction v-r
12
v-r 800
12
refraction
11
conventional
8
subjective refraction
8
refraction conventional
8

Similar Publications

"Characterization of visual function parameters in relation to macular pigment optical density in a pediatric population".

Graefes Arch Clin Exp Ophthalmol

September 2025

Department of Physics of Condensed Matter, Optics Area. Vision Research Group (CIVIUS), University of Seville, Avenida de la Reina Mercedes s/n (41012), Seville, Spain.

Purpose: To analyze the relationship between various visual function parameters (refractive status, visual acuity and contrast sensitivity) and macular pigment optical density (MPOD) values, as well as dietary intake of lutein and zeaxanthin in a pediatric population.

Methods: Thirty-six healthy White pediatric patients participated in this cross-sectional study conducted at the Optometry Clinic (Faculty of Pharmacy, Seville, Spain). MPOD values were measured using the MPSII (Macular Pigment Screener II).

View Article and Find Full Text PDF

Purpose: To evaluate visual, anatomical and safety outcomes of aflibercept 8 mg in previously treated patients with neovascular age-related macular degeneration (nAMD).

Methods: This retrospective study included nAMD patients switched to aflibercept 8 mg from prior anti-VEGF therapies at Sahlgrenska University Hospital between February 2024 and February 2025. Data on best-corrected visual acuity (BCVA), central retinal thickness (CRT), pigment epithelial detachment (PED) height, fluid status, treatment intervals, time to fluid recurrence and adverse events were collected.

View Article and Find Full Text PDF

Temporary silicone oil tamponade for persistent macular holes: a multicentre study.

Br J Ophthalmol

September 2025

Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

Background: Persistent full-thickness macular holes (FTMHs) following primary surgery represent a therapeutic challenge. Various surgical treatment approaches have been proposed. This study evaluates anatomical and functional outcomes of a temporary silicone oil tamponade in persistent FTMH in a larger cohort.

View Article and Find Full Text PDF

Correlations Between Variability of Preoperative Ocular Biometric Measurements and Accuracy of Intraocular Lens Power Calculation.

Photodiagnosis Photodyn Ther

September 2025

Department of Ophthalmology, The People's Hospital of Baoan Shenzhen, Shenzhen 518000, China; Department of Ophthalmology, The Second Affiliated Hospital of Shenzhen University, Shenzhen 518000, China. Electronic address:

Objectives: To investigate the relationship between variability of preoperative ocular biometric measurements and the accuracy of intraocular lens (IOL) power calculation.

Methods: This retrospective study included cataract patients who underwent surgery at the People's Hospital of Baoan Shenzhen from January 2022 to December 2024. Preoperative ocular biometric parameters were measured using the Lenstar LS-900, and the coefficients of variation (CV) of corneal curvature (K1-CV, K2-CV), axial length (AL-CV), anterior chamber depth (ACD-CV) were calculated.

View Article and Find Full Text PDF

Purpose: We report the efficacy and safety of voretigene neparvovec (VN) as an adeno-associated viral vector-based gene therapy for Japanese patients with inherited retinal dystrophy caused by biallelic pathogenic variants (-retinopathy).

Design: Open-label, single arm, phase III clinical trial.

Participants: Four subjects were recruited based on the following criteria: (1) a clinical and molecular genetic diagnosis of -retinopathy; (2) age ≥4 years; (3) a best-corrected VA (BCVA) worse than 20/60 or a visual field (VF) <20° by a III4e isopter or equivalent; and (4) sufficient viable retinal cells by OCT or ophthalmoscopy.

View Article and Find Full Text PDF